Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Triple Negative Breast Cancer|Safety Issues|Efficacy
Interventions: DRUG: Bevacizumab
Sponsor: Assiut University